These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17898885)

  • 1. [Response to anti-TNF-alpha treatment for secondary renal amyloidosis in a patient with ankylosing spondylitis].
    Bellissimo S; Ferrucci MG; Gallo A; Stisi S
    Reumatismo; 2007; 59(3):240-3. PubMed ID: 17898885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of etanercept on a case of amyloidosis secondary to ankylosing spondylitis: results of 2-year follow-up.
    Yilmaz H; Kocabas H; Erkin G
    Acta Reumatol Port; 2013; 38(4):299-301. PubMed ID: 24435036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients.
    Kobak S; Oksel F; Kabasakal Y; Doganavsargil E
    Clin Rheumatol; 2007 Dec; 26(12):2191-2194. PubMed ID: 17611708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
    Barthel HR
    Arthritis Rheum; 2001 Aug; 45(4):404. PubMed ID: 11501730
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary amyloidosis in ankylosing spondylitis.
    Dönmez S; Pamuk ÖN; Pamuk GE; Aydoğdu E; Inman R
    Rheumatol Int; 2013 Jul; 33(7):1725-9. PubMed ID: 23283540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
    Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
    J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Remission of Nephrotic Syndrome Without Resolution of Amyloid Deposit After Anti-Tumor Necrosis Factor α Therapy in a Patient With Ankylosing Spondylitis.
    Lee YH; Kim EY; Jeong DW; Kim YG; Lee SH; Song R; Yang HI; Lim SJ; Moon JY; Lee SH
    J Clin Rheumatol; 2016 Mar; 22(2):86-8. PubMed ID: 26906302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
    Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
    Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis.
    Perry ME; Stirling A; Hunter JA
    Clin Rheumatol; 2008 Jul; 27(7):923-5. PubMed ID: 18379834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensorineural hearing loss in ankylosing spondylitis treated with TNF blockers.
    Savastano M; Marioni G; Giacomelli L; Ramonda R; Ferraro SM; Punzi L
    B-ENT; 2010; 6(3):183-8. PubMed ID: 21090160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
    Clin Rheumatol; 2010 Dec; 29(12):1395-401. PubMed ID: 20440529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective.
    Nobre CA; Callado MR; Rodrigues CE; de Menezes DB; Vieira WP
    Rev Bras Reumatol; 2010; 50(2):205-10. PubMed ID: 21125155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis.
    Smith GR; Tymms KE; Falk M
    Intern Med J; 2004; 34(9-10):570-2. PubMed ID: 15482271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept: in ankylosing spondylitis.
    McCormack PL; Wellington K
    BioDrugs; 2004; 18(3):199-205; discussion 206. PubMed ID: 15161337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TNF-alpha therapy for ankylosing spondylitis.
    Son JH; Cha SW
    Clin Orthop Surg; 2010 Mar; 2(1):28-33. PubMed ID: 20190998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept: new indication. For ankylosing spondylitis: another option.
    Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
    Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
    J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].
    Rudwaleit M; Sieper J
    Dtsch Med Wochenschr; 2005 Aug; 130(33):1882-6. PubMed ID: 16118732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.